These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16770860)

  • 1. The Canadian agency for the oversight of research involving humans: a reform proposal.
    Downie J
    Account Res; 2006; 13(1):75-100. PubMed ID: 16770860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is national, independent oversight needed for the protection of human subjects?
    Capron AM
    Account Res; 1999; 7(2-4):283-92. PubMed ID: 11658183
    [No Abstract]   [Full Text] [Related]  

  • 3. The institutional review board and beyond: future challenges to the ethics of human experimentation.
    Edgar H; Rothman DJ
    Milbank Q; 1995; 73(4):489-506. PubMed ID: 7491097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical and legal considerations in dental caries research involving human subjects.
    Branson R
    J Dent Res; 1980 Jul; 59(Special Issue C):1214-364. PubMed ID: 11651755
    [No Abstract]   [Full Text] [Related]  

  • 5. Harmonizing regulations for biomedical research: a critical analysis of the US and Venezuelan systems.
    Di Tillio-Gonzalez D; Fischbach RL
    Dev World Bioeth; 2008 Dec; 8(3):167-77. PubMed ID: 17488491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human embryonic stem cell research: an argument for national research review.
    Baylis F; Robert JS
    Account Res; 2006; 13(3):207-24. PubMed ID: 17124758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to interpret the federal policy for the protection of human subjects or "Common Rule" (Part A). [for the Working Group of the Human Subjects Research Subcommittee of the National Science and Technology Council].
    Shelton JD
    IRB; 1999; 21(6):6-9. PubMed ID: 11697393
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations for federal "super agency" would affect institutional review boards.
    Maloney DM
    Hum Res Rep; 2001 Feb; 16(2):1-3. PubMed ID: 12530378
    [No Abstract]   [Full Text] [Related]  

  • 9. Widespread IRB-related compliance problems at research institution.
    Maloney DM
    Hum Res Rep; 2001 Jan; 16(1):6-7. PubMed ID: 11855427
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurobiological research involving human subjects: perspectives from the Office for Protection from Research Risks.
    Puglisi JT; Ellis GB
    Account Res; 1996; 4(3-4):261-5. PubMed ID: 11654521
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishment of ethical oversight of human research in El Salvador: lessons learned.
    Caniza MA; Clara W; Maron G; Navarro-Marin JE; Rivera R; Howard SC; Camp J; Barfield RC
    Lancet Oncol; 2006 Dec; 7(12):1027-33. PubMed ID: 17138224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for "research involving human subjects"--What is examined? What is exempt? What is exasperating?
    Pritchard IA
    IRB; 2001; 23(3):5-13. PubMed ID: 11789525
    [No Abstract]   [Full Text] [Related]  

  • 13. National commission proposes numerous new regulations of institutional review boards.
    Maloney DM
    Hum Res Rep; 1998 Oct; 13(10):1-2. PubMed ID: 11657739
    [No Abstract]   [Full Text] [Related]  

  • 14. National, independent oversight: reinforcing the safety net for human subjects research.
    Mastroianni AC
    Account Res; 1999; 7(2-4):303-9. PubMed ID: 11658185
    [No Abstract]   [Full Text] [Related]  

  • 15. An introduction to NBAC's report on research involving persons with mental disorders that may affect decisionmaking capacity.
    Childress JF
    Account Res; 1999; 7(2-4):101-15. PubMed ID: 11658169
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond localism: a proposal for a National Research Review Board.
    Levine C; Caplan AL
    IRB; 1986; 8(2):7-9. PubMed ID: 11649751
    [No Abstract]   [Full Text] [Related]  

  • 17. Institutional review of medical research. Cost-benefit analysis, risk-benefit analysis, and "the possible effects of research on public policy".
    Schwartz RL
    J Leg Med; 1983 Jun; 4(2):143-66. PubMed ID: 6411846
    [No Abstract]   [Full Text] [Related]  

  • 18. NIH guidelines for research involving recombinant DNA molecules.
    Wilson DJ
    Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
    [No Abstract]   [Full Text] [Related]  

  • 19. The history of institutional review boards.
    Sherman M; Van Vleet JD
    Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
    [No Abstract]   [Full Text] [Related]  

  • 20. DHHS internal policies for reviewing research involving children.
    Reatig N
    IRB; 1981 Jan; 3(1):1-4. PubMed ID: 11661894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.